Sichenzia Ross Ference LLP

Author Archives: Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice. Visit SRF's LinkedIn page

Litigation Associate

We are looking for a litigation associate with 2 to 3 years’ experience, well versed in Securities law & FINRA regulations and compliance.  In addition, should possess experience in Securities Litigation and Arbitration; defending claims unique to the financial services industry, including claims for fraud, conversion, unsuitability, churning, failure to supervise  and unauthorized trading as well as knowledge of the financial services industry.  Excellent writing and research skills.  Experience with representing broker-dealers is preferred.  New York bar required.

Please send resumes to tbarone@srf.law

Sichenzia Ross Ference LLP Obtains Dismissal of $2.6 Million Contract Claims On Appeal

Press release- New York, NY – October 15, 2020 – Sichenzia Ross Ference LLP obtained dismissal today of $2.6 million in contractual claims against its corporate client and the company’s president in an appeal to the First Department, Appellate Division in Moiseenko et al. v. AGA Management Corp. et al.  The Supreme Court, New York County, had previously determined that the Plaintiffs’ employment contract was ambiguous as to whether Plaintiffs were owed $50,000 every other week, or $50,000 annually.  The First Department reversed the Supreme Court and granted summary judgment to the firm’s clients, dismissing the Plaintiff’s claim, holding that the “only reasonable reading” of the contract was that Plaintiffs were entitled to a $50,000 annual salary.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $7.5 Million At-The-Market Offering of Ekso Bionics

Press Release – New York, NY – October 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sales agent in a $7.5 million At-The-Market Offering (“ATM”) of Ekso Bionics Holdings, Inc. (NASDAQ: “EKSO”) common stock.

The shares were registered on EKSO’s registration statement on Form S-3 (File No. 333-239203), which was declared effective by the SEC on June 26, 2020, and prospectus supplement relating to the ATM filed with the SEC on October 9, 2020.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, Avital Perlman, Barrett DiPaolo and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $15 Million Initial Public Offering of Amesite Inc.

amesite logo

Press Release – New York, NY – September 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. in the $15 million initial public offering of Amesite Inc., an artificial intelligence software company providing online educational programs for  K-12, college, university and business education, and upskilling. 3,000,000 shares were sold to the public at a price of $5.00 per share. Amesite’s common stock began trading on the Nasdaq Capital Market under the ticker symbol “AMST” on September 25, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.25 Million Initial Public Offering of Greenwich LifeSciences, Inc.

greenwich lifesciences logo

Press Release – New York, NY – September 29, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the initial public offering of 1,260,870 shares of the common stock of Greenwich LifeSciences, Inc. (NASDAQ: GSLI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. The shares were sold to the public at at a price of $5.75 per share for gross proceeds of approximately $7,250,000.

continue reading >>

Sichenzia Ross Ference Partner Andrew M. J. Bernstein, Esq. to Present Grand Jury CLE for Lawline

Sichenzia Ross Ference partner, and leader of the firm’s White-collar Defense and Investigations
practice, Andrew M. J. Bernstein will be presenting “New York State Grand Jury Practice for
Criminal Defense Attorneys” on Monday September 28, 2020 at 4:00 P.M. The CLE course,
presented by Lawline, will be live-streamed that day and the recording will be available any time
after online at https://www.lawline.com.

Focusing on New York State grand jury practice, the CLE course will cover: the law governing
grand juries, grand jury presentations, and how to effectively represent defendants who will be or
are considering testifying before a grand jury. Last month, Mr. Bernstein gave a similar
presentation for the New York State Bar Association.

SIGN UP HERE

Founding Partner Gregory Sichenzia Quoted in Bankrate Article Discussing Prominent IPOs to Keep an Eye On

Press Release – New York, NY – September 15, 2020 – Sichenzia Ross Ference founding partner Gregory Sichenzia was featured in a Bankrate article entitled “IPOs have gone red hot in 2020: Here are 7 big names to watch.” Sichenzia shared his opinion that with interest rates being at near record lows, investors are limited in where they can allocate capital, which is why the equities market and more specifically IPOs have been so attractive. Please read the full article here.

Sichenzia Ross Ference LLP Represents Vuzix in $15.5 Million Registered Direct Offering

vuzix

Press Release – New York, New York – September 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, in a registered direct offering of 3,647,060 shares of its common stock and 6 month common stock purchase warrants. The common stock was sold at a price of $4.25 per share and the warrants have an exercise price of $5.25 per share. The gross proceeds from the offering will be approximately $15,500,000. 

The Sichenzia Ross Ference LLP team was led by Partner Gregory Sichenzia, Counsel Jeffrey Cahlon, and Associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.2 Million Underwritten Public Offering of Avinger Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 11,063,830 shares of common stock of Avinger, Inc. (NASDAQ: “AVGR”), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD). The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).

continue reading >>

Sichenzia Ross Ference LLP Represents Roth Capital Partners, LLC as Sole Bookrunner in $23.5 Million Public Offering of Centrus Energy Corp. Common Stock

Centrus energy corp logo

Press Release – New York, NY – August 25, 2020 – Sichenzia Ross Ference LLP today
announced that it represented Roth Capital Partners, LLC as sole bookrunner, with Lake Street
Capital Markets LLC, as lead manager, in an underwritten public offering of 2,350,000 shares of
the common stock of Centrus Energy Corp. (NYSE American: LEU), a global energy company that
supplies low enriched uranium (“LEU”) for commercial nuclear power plants, at a price of
$10.00 per share.

continue reading >>

Sichenzia Ross Ference Partner Andrew M. J. Bernstein, Esq. Will Present at the Next Installment of The New York State Bar Association’s 2020 Trial Academy Virtual Conference Series: “Grand Jury Presentations and Representing Clients in the Grand Jury,” on Friday, August 21, 2020 from 2:00 – 4:00 p.m.

Sichenzia Ross Ference partner, and leader of the firm’s white-collar defense practice, Andrew M. J. Bernstein will be presenting at “Grand Jury Presentations and Representing Clients in the Grand Jury.” The presentation, which is Continuing Legal Education (“CLE”) accredited, is part of the New York State Bar Association’s (NYSBA) 2020 Trial Academy Virtual Conference series. The program will be held, on-line, Friday, August 21, 2020 from 2:00 – 4:00 p.m., and will also feature Catherine A. Christian, Esq., Senior Assistant District Attorney from the New York County District Attorney’s Office, Special Victims Bureau.

Mr. Bernstein will discuss what defense attorneys, representing individual and corporate clients, should consider before their clients appear before a grand jury as either a defendant in a criminal case, a target of an ongoing investigation or as a witness. Mr. Bernstein will also cover how to effectively prepare clients to testify in front of the grand jury and other crucial defense strategies to employ.

SIGN UP HEREProduct Code: 0HY3E

Founding Partner Gregory Sichenzia Participates on CLE Webinar Examining PIPEs and Registered Direct Offerings

Sichenzia Ross Ference founding partner Gregory Sichenzia participated in a webinar for Strafford, titled “PIPE Transactions and Registered Direct Offerings: Alternative Capital Raising, PE Investment Opportunity,” on Thursday, August 6. This presentation, which is Continuing Legal Education (“CLE”) accredited, examines the mechanics of traditional private investments in public equity (PIPEs) as well as registered direct offerings.

Among the topics reviewed by Sichenzia and other panel members were the following key issues:

  • What are the key advantages of PIPE transactions over a traditional offering of securities?
  • How has COVID-19 impacted public offerings of securities and the use of PIPEs as an alternative financing vehicle?
  • What are the essential terms and negotiating points for traditional PIPEs?
  • Why might a registered direct transaction be preferred over a standard PIPE transaction? Are there any additional registration requirements?

Please find the full link to the webinar here.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $6 Million Public Offering of Avinger Inc. Common Stock

avinger logo

Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $10 Million Initial Public Offering of 1847 Goedeker Inc. Common Stock

goedekers logo

Press Release – New York, NY – August 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole book-runner in the initial public offering of the common stock of 1847 Goedeker Inc. (NYSE: GOED), a one-stop e-commerce destination for appliances, furniture, home goods, and related products. The offering was comprised of 1,111,200 shares of common stock at a price of $9.00 per share for gross proceeds of $10,000,800, less underwriting discounts and offering expenses. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in Close of $3.4 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – July 31, 2020 – Sichenzia Ross Ference LLP represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 453,333 shares of the company’s common stock at a price of $7.50 per share, for gross proceeds to DSS of $3.4 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

continue reading >>

Relief for Retirement Account Owners During COVID-19

The Coronavirus Aid, Relief, and Economic Security (CARES) Act that was signed into law on March 27, 2020 modifies the existing rules governing retirement accounts and helps taxpayers improve their cash flow. Here we highlight (1) the waiver of the 10% penalty applicable to early withdrawals, (2) the enhanced loan provisions, and (3) the suspension of the Required Minimum Distribution rules.  Please consult with your tax advisor to determine how you may take advantage of these new rules.

continue reading >>

Sichenzia Ross Ference LLP Represents Immuron Limited in $20 Million Registered Direct Offering

immuron logo

Press Release – New York, NY – July 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, in a registered direct offering of 1,066,668 American Depositary Shares (“ADSs”), each ADS representing 40 of the Company’s ordinary shares, at a purchase price of $18.75 per ADS for gross proceeds of approximately $20 million.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $5.9 Million Registered Direct Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – July 22, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of Safe-T Group Limited (NASDAQ: “SFET”) for gross proceeds of approximately $5.9 million. The offering provided for the issuance of an aggregate of (i) 3,075,000 American depositary shares (“ADSs”) at a purchase price of $1.40 per ADS, and (ii) 1,145,000 pre-funded warrants each to purchase one ADS (“Pre-Funded Warrants”) at a price of $1.40 each, including the Pre-Funded Warrant exercise price of $0.001 per full ADS. The Pre-Funded Warrants will be exercisable at any time after the date of issuance.  continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $5.1 Million Public Offering

genetic technologies logo

Press Release – New York, NY – July 20, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,025,000 American Depositary Shares (the “ADSs”), each representing six hundred of the Company’s ordinary shares, at a purchase price of $5.00 per ADS, for gross proceeds of $5.1 million.

continue reading >>

Sichenzia Ross Ference LLP Represents Zynex, Inc. and Selling Shareholder in $55 Million Public Offering of Common Stock

zynexmedical logo

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP today announced that it represented Zynex, Inc. (NASDAQ: “ZYXI”), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, and a certain shareholder in a public offering of an aggregate of 2,500,000 shares of its common stock at a public offering price of $22.00 per share. The offering was made pursuant to a registration statement on Form S-3 (File No. 333-230128) that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on March 12, 2019, and a registration statement on Form S-3 (File No. 333-232367) that was filed with the SEC and became effective on July 3, 2019, for the shares of common stock being offered by ZYXI and the selling stockholder, respectively.

continue reading >>

Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock

inmunebio logo

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP announced that it represented INmune Bio Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, in a public offering of 2,173,914 shares of the company’s common stock at a price of $10.00 per share.  The gross proceeds to INMB were $21.74 million, before deducting underwriting discounts and other offering expenses, with net proceeds estimated to be $20 million. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-237368), that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on April 2, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Equillium, Inc. in $150 Million At-The-Market Offering Through Jeffries LLC 

equilliam logo

Press Release – New York, NY – July 16, 2020 – Sichenzia Ross Ference LLP announced that it represented Equillium, Inc. (NASDAQ: “EQ”), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, in an At-The-Market Offering (“ATM”), whereby Equillium may sell up to $150 million of common stock from time-to-time.  Jefferies LLC is acting as the sales agent in connection with the ATM.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright as Sales Agent in $7 Million At-The-Market Offering of BioPath Holdings

bio-path holdings inc logo

Press Release – New York, NY – July 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC, as sales agent in an At-The-Market Offering (“ATM”) of BioPath Holdings Inc (NASDAQ: “BPTH”) common stock for gross proceeds of approximately $7 million. The shares were registered on BPTH’s Registration Statement on Form S-3 (File No. 333-231537) filed with the Securities and Exchange Commission on May 16, 2019, and declared effective by the SEC on June 5, 2019, and the prospectus supplement relating to the ATM filed with the SEC on July 14, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6.43 Million Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – July 7, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 1,028,800 shares of the company’s common stock at a price of $6.25 per share, for gross proceeds to DSS of $6.43 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – June 26, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 20,000,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.27 per share, for total gross proceeds of approximately $5.4 million.  Avinger is a leading developer of innovative treatments for peripheral artery disease. 

continue reading >>

Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering 

china internet nationwide financial services

Press Release – New York, NY – June 24, 2020 – Sichenzia Ross Ference LLP today announced that it represented Hudson Capital Inc.  (NASDAQ: HUSN), in a $3.7 million registered direct offering of its ordinary shares at a price of $0.85 per share. The offering was made pursuant to a registration statement on Form F-3 (File No. 333-233408) which was previously filed with the Securities and Exchange Commission and declared effective on September 19, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6 Million Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 769,230 shares of the company’s common stock at a price of $7.80 per share. The offering was made pursuant to a registration statement on Form S-1 (File No. 333-238587) which was previously filed with the Securities and Exchange Commission and declared effective on June 16, 2020. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.4 Million Public Offering of Digital Ally, Inc. Common Stock

digital ally logo

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,325,581 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company, at a price of $2.15 per share. The underwriters elected to simultaneously close the over-allotment option consisting of 213,953 shares of common stock, bringing the offering’s gross proceeds to approximately $5.4 million, before deducting underwriting discounts and other offering expenses.

continue reading >>

Founding Partner Marc J. Ross, Esq. Presents Legal Webinar on The Ethical Considerations for an Attorney Advising Clients Engaged In a Marijuana-Related Business

Sichenzia Ross Ference founding partner Marc J. Ross, Esq. will be presenting a webinar course for the Clear Law Institute, titled “The Ethical Considerations for an Attorney Advising a Client Engaged In a Marijuana-Related Business,” on Friday, June 12, 2020 at 3:00 pm. This presentation, which is Continuing Legal Education (“CLE”) accredited, will explore the ethical concerns and practices related to attorneys advising clients that are engaged in marijuana-related business.

To register and participate in this Webinar, please visit the website here include speaker code MRoss291348 for a 35% discount, and pass it along to anyone you think might be interested.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.1 Million Public Offering of Digital Ally, Inc. Common Stock

digital ally logo

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 3,090,909 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.65 per share for gross proceeds of approximately $5.1 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

genetic technologies logo

Press Release – New York, NY – May 28, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a public offering of 4,000,000 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman, counsel Jeffrey Cahlon, and associate Yian Pan.

Marc J. Ross, Esq. Presents a Legal Webinar Explaining the Confusion Surrounding Marijuana Law

Having just finished teaching his fifth successful year of “The Business and Law of Marijuana” at Hofstra University School of Law, SRF founding partner Marc J. Ross, Esq. recently presented a webinar course for the Clear Law Institute, titled “Weeding Out the Confusion in Marijuana Law.”

This webinar, which is Continuing Legal Education (“CLE”) accredited, took place on Monday, May 11, 2020 at 3:00 pm. During the presentation, Marc discussed the confusing and often contradictory laws concerning marijuana for marijuana-related businesses and, amongst other things, address how current federal law remains in stark contrast to the majority of state laws; explain the origins and development of the differing current laws; identify certain areas of the law that should be particularly concerning; and finally, delineate how and why CBD is different, both on the federal and state level.

To access this webinar, please visit the website and include speaker code MRoss289594 for a 35% discount.

 

Sichenzia Ross Ference Founding Partner Marc J. Ross, Esq. to Present Legal Webinar on Federal Regulation Governing Marijuana-Related Businesses

Sichenzia Ross Ference founding partner Marc J. Ross, Esq will present a webinar course for the Clear Law Institute, titled “Federal Regulation Governing the Operation of Marijuana-Related Business,” on Tuesday, May 26, 2020 at 3:00 pm.

This presentation, which is Continuing Legal Education (“CLE”) accredited, we will explore how Federal law enforcement and other Federal regulatory agencies govern and impact the operation of marijuana-related business. Upon course completion, you will be able to recognize, identify, and describe:

  • Potential criminal issues raised by the United States Department of Justice
  • Potential banking issues raised by the United States Department of Treasury
  • Potential tax issues raised by the United States International Revenue Code
  • Potential issues with securities as raised by the United States Securities and Exchange Commission and United States listed exchanges
  • Potential insolvency issues related to the United States bankruptcy laws

To register and participate in this Webinar, please visit the website here and include speaker code MRoss290814 for a 35% discount, and pass it along to anyone you think might be interested.

Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd 

Medigus Ltd logo

Press Release – New York, NY – May 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager in a $5 million offering of Medigus Ltd. (Nasdaq: MDGS), an Israeli technology company developing minimally-invasive tools and direct visualization technology.  

continue reading >>

Estate Planning During COVID-19

COVID-19 is a harsh reminder that life is fragile and unpredictable. The pandemic has caused many people to acknowledge their mortality and to reevaluate their financial circumstances and life goals.  In these rather difficult and uncertain times, the importance of being prepared for a worst-case scenario and having certain essential estate planning documents in place is, unfortunately, paramount.  At a minimum, every client should establish (or update) the following in order to protect themselves, their loved ones, and their legacy:

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering

vuzix view the future logo

Press Release – New York, New York – May 13, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI) in a registered direct offering of 5,000,000 shares of its common stock at a price of $2.25 per share for gross proceeds of approximately $11,250,000. 

The Sichenzia Ross Ference LLP team was led by partner Gregory Sichenzia, counsel Jeffrey Cahlon, and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

lexaria bioscience logo

Press Release – New York, New York – May 7, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common stock and warrants for gross proceeds of approximately $2 million. 

The Special Equities Group, a division of Bradley Woods & Co. Ltd., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.25 per share, for total gross proceeds of approximately $3.15 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

60 Days And Counting: “Regulation Best Interest” Is Nearly Here. Are Independent Broker-Dealers Ready? What They Need to Know and Do

On June 5, 2019, the United States Securities and Exchange Commission (“Commission”) adopted Rule 15l-1 (“Regulation Best Interest”) under the Securities Exchange Act of 1934 (“Exchange Act”), which has a compliance date of June 30, 2020.[1]  Regulation Best Interest became effective September 10, 2019.  Notwithstanding the host of issues arising from the global pandemic, an economic recession and significant market volatility across essentially every sector, the Commission has made clear that the deadline for compliance with Regulation Best Interest and the related Form CRS requirements will not be delayed or extended.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $8.4 Million Underwritten Public Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented A.G.P./Alliance Global Partners as sole book-running manager in an underwritten public offering of the securities of Safe-T Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments. The securities offered by the company consisted of (i) 858,600 units, each comprised of one American Depositary Share (“ADS”), representing 40 ordinary shares, and one warrant to purchase one ADS (“Warrant”), and (ii) 6,777,500 pre-funded units, each comprised of one pre-funded warrant to purchase one ADS and one Warrant.  The offering price was $1.10 per unit and $1.099 per pre-funded unit. 

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering

beyond air logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in an At-The-Market Offering (“ATM”) under which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.44 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 722,502 American Depositary Shares (ADSs), each representing 600 of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.8 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 3, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,028,574 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $1.75 per ADS.

continue reading >>

SEC Extends Filing Deadlines for Public Companies and Registered Investment Advisers Affected by COVID-19

On March 25, 2020, the Securities and Exchange Commission (the “SEC”) issued new orders extending the filing periods covered by its previously enacted conditional reporting relief for certain public company filing obligations under the federal securities laws, and also extended regulatory relief previously provided to funds and investment advisers whose operations may be affected by COVID-19.

continue reading >>

Business Interruption Insurance

Dear Clients and Friends,

With widespread government ordered shutdowns resulting from the COVID-19 pandemic, companies are understandably concerned with the interruption to their business operations as well as the financial and economic losses that are beginning to mount. In light of this, it is important that companies take the time to look at their existing insurance policies to examine what options are available to mitigate the impact of the COVID-19 pandemic. The viability of a claim for losses under your existing Property, Event and/or Comprehensive General Liability policies caused by a pandemic or “communicable or infectious diseases” will be largely subject to the specific provisions of your company’s insurance policies.

Sichenzia Ross Ference LLP recommends that all its clients carefully review their insurance policies, including without limitation their Property, Event and Commercial General Liability policies, to determine the scope of coverage for business interruption with particular focus on whether any of those policies include or exclude coverage for losses caused by a communicable or infectious disease such as COVID-19.

We, at Sichenzia Ross Ference LLP, continue to think about our clients and friends during these trying times, and, if there are any ways we might be able to help, ask that you contact us.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.7 Million Overnight Bought Offering of Cel-Sci Common Stock

cel sci

Press Release – New York, NY – March 26, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book-running manager in an offering of 630,500 shares of the common stock of Cel-Sci Corporation (NYSE American: CVM), a biotechnology company. The stock was offered at $12.22 per share for gross proceeds of approximately $7.7 million, less underwriting discounts and other offering expenses.  

continue reading >>

Coronavirus (Covid 19) Update

At Sichenzia Ross Ference LLP, people are our priority. As the world struggles to manage through the impact of the coronavirus (COVID-19), we want to assure you that we are committed to supporting our colleagues, clients, friends and communities as effectively as we have through every other crisis over the decades.

  • Our firm is fully operational: We have adapted and activated our business continuity plans to ensure that our lawyers and team members are able to safely serve our clients’ needs and continue operations on an uninterrupted basis, whether working from our offices or remotely.
  • We encourage you to contact us with any concerns that you may have or topics that you would like to discuss; we are here to support you through these challenging times. Please continue to contact us at the same phone numbers and email addresses that you are accustomed to using.
  • As disruptive as these days are for our clients and colleagues, we know that this virus and efforts to stop its spread will have an even greater impact on the most vulnerable members of our society. Our thoughts go out to all those whose health has been or will be affected by this virus, and our gratitude goes to all the first responders and health care workers courageously working every day to help those who are ill.

We are all in this together, and we will get through it together.

Our thoughts are with you and your loved ones to stay safe and be well.

Founding Partner Gregory Sichenzia Featured in Law360 Article on Coronavirus-fueled Market Volatility

Press Release – New York, NY – March 10, 2020 – Sichenzia Ross Ference LLP today shared that founding name partner Gregory Sichenzia was quoted in Law360 by reporter Tom Zanki in his story, “Market Turbulence Throws IPO Pipeline Into Question.” The story discussed market volatility and IPO plans amid the coronavirus outbreak, including commentary from Sichenzia:

No IPOs are scheduled yet for next week, according to New York Stock Exchange and Nasdaq calendars. Sichenzia Ross Ference LLP partner Greg Sichenzia expects that companies that have not launched roadshows yet will wait for stability before moving forward.

“If you can keep your powder dry, you will,” said Sichenzia, who counsels public and private companies.

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Pareteum Corporation (NASDAQ: TEUM), a cloud communications platform company, as it entered into a subscription agreement with certain investors for shares of the company’s 8% Series C Redeemable Preferred Stock at a purchase price of $100,000 per share for gross proceeds of $3,750,000.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associate Grant Levine.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $2.9 Million Public Offering of Digital Ally, Inc. Common Stock 

digital ally logo

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,521,740 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.15 per share for gross proceeds of approximately $2.9 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Alliance Global Partners as Placement Agent in $10M Registered Direct Offering of Aptorum Group Limited

Aptorum logo

Press Release – New York, NY – February 28, 2020 – Sichenzia Ross Ference LLP announced today that it represented Alliance Global Partners as lead placement agent in a registered direct offering of 1,351,350 Class A ordinary shares of Aptorum Group Limited (Nasdaq: “APM”), a biopharmaceutical company. The offering price was $7.40 per share for gross proceeds of $10 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $4.6 Million Public Offering of Common Stock 

document security systems logo

Press Release – New York, NY – February 25, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and diversion protection technologies, in the underwritten public offering of 22,222,223 common shares, plus 3,333,333 shares from the exercise of the underwriter’s purchase option to cover overallotments, at a price of $0.18 per share for gross proceeds of $4.6 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.6 Million Offering of Medalist Series A Stock

medalist diversified reit logo

Press Release – New York, NY – February 19, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 200,000 shares of 8% Series A Cumulative Redeemable Preferred Stock of Medalist Diversified REIT, Inc. (Nasdaq:MDRR), a real estate investment trust specializing in the acquisition, ownership and management of value-add commercial real estate.  The shares were sold at an offering price of $23.00 per share for gross proceeds of $4.6 million and commenced trading on the Nasdaq Capital Market under the symbol “MDRRP.”

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $8.1 Million Offering and NASDAQ Listing of Duos Technologies Common Stock

duostech logo

Press Release – New York, NY – February 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager and The Benchmark Company as co-manager in an $8.1 million offering of common stock at $6.00 per share of Duos Technologies Group, Inc. (NASDAQ: DUOT). Simultaneously with the offering, the common stock was approved for listing on the Nasdaq Capital Market and began trading on February 13, 2020 under the symbol DUOT. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Follow-On Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – February 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 6,428,572 shares of the common stock of Avinger, Inc.  (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease, at an offering price of $0.70 per share for gross proceeds of $4.5 million. The shares are being offered and sold pursuant to Avinger’s effective registration statement on Form S-1 (Registration No. 333-235902).

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P. in $2.2 Million Common Stock Offering

co crystal pharma inc

Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc.  (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics.  The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).

continue reading >>

Sichenzia Ross Ference LLP Represents HiVentures Zrt., a Hungarian Venture Capital Company, in Private Placement of Series A Preferred Stock of ActiveGraf

activegraf logo

Press Release – New York, NY – January 16, 2020 – Sichenzia Ross Ference LLP announced today that it represented MFB Növekedési Tökealap, a Hungarian investment firm, and its manager, Hiventures Zrt., a state-owned venture capital company committed to the promotion of Hungarian start-ups and businesses, in connection with their agreement to purchase approximately $900,000 of Series A preferred stock of ActiveGraf Inc., a private North Carolina-based company creating interactive data analytics.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Successfully Defends Client in Hostile Proxy Contest

Press Release – New York, NY – January 7, 2020 – Sichenzia Ross Ference LLP successfully defended its client, Document Security Systems, Inc., against dissident shareholders.  The shareholders abandoned their efforts after filing an insurgent proxy statement relating to the company’s December 9, 2019 annual meeting. The meeting was held as scheduled and the Board’s recommended slate of candidates was elected.

The SRF team was led by partners Gregory Sichenzia, Darrin Ocasio, Marcelle Balcombe, Barrett DiPaolo, and Jay Yamamoto and associate Matthew Siracusa.

SRF CLIENT ALERT: Major Changes for Your IRA Account

Congress has made major changes for IRA accounts effective January 1, 2020:

The End of the Stretch IRA

Before 2020, anyone who inherited an IRA account was able to delay taking distributions from it over the course of his or her lifetime.  This frequently enabled the IRA beneficiary to stretch out the mandatory withdrawals over many decades, meanwhile allowing the IRA account to build up on a tax-deferred basis.  Beginning in 2020, with certain exceptions, anyone who inherits an IRA will have to take all of it out within 10 years.  The timing of the withdrawals during the 10 years is up to the beneficiary, but by the end of 10 years the entire account has to be taken down and all of the deferred income taxes have to be paid.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.5 Million Follow-On Offering of CEL-SCI Corporation Common Stock

cel sci

Press Release – New York, NY – December 30, 2019 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 606,395 shares of the common stock of CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, at an offering price of $9.07 per share, for gross proceeds of $5.5 million. Pursuant to the terms of the underwriting agreement, Aegis has been granted a 45-day option to purchase up to an additional 90,959 shares of CEL-SCI common stock to cover over-allotments.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Avital Perlman and Marcelle Balcombe and associates Grant Levine and Jacob Tabman.

Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock

biotricity logo

Press Release – New York, New York – December 19, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, in connection with the sale of $6M of its Series A convertible preferred stock.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference LLP Achieves Voluntary Dismissals in Federal Securities Class Action Lawsuit and Shareholder Derivative Action

Press Release – New York, NY – December 16, 2019 – Sichenzia Ross Ference LLP (SRF) achieved voluntary dismissals in two lawsuits on behalf of its client, Vuzix Corporation (“Vuzix” or “Company”), a leading developer and supplier of Smart Glasses and Augmented Reality Glasses.  SRF represented the Company in consolidated class action lawsuits alleging violations of federal securities laws before the United States District Court for the Southern District of New York (“Class Action”), and in consolidated shareholder derivative actions before the New York State Supreme Court for Monroe County (“Derivative Action”).  The Plaintiffs ultimately dropped both actions.

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement

beyond air logo

Press Release – New York, NY – December 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a clinical stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for treatment of severe respiratory conditions, in the successful completion of an underwritten public offering and concurrent private placement of approximately $11.5 million of Beyond Air common stock at a price of $3.66 per share. The public offering was conducted from an effective shelf registration statement filed with the Securities and Exchange Commission.  The private placement shares will not be registered.

continue reading >>

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock

relmada

Press Release – New York, NY – December 6, 2019 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression and central nervous system disease therapies, in the successful completion of an underwritten public offering of three million shares of Relmada common stock at a price of $30.00 per share.

The underwriters exercised their over-allotment option for an additional 450,000 shares, bringing gross proceeds to $115 million before the deduction of underwriting discounts, commissions, and other estimated offering expenses. Jefferies, SVB Leerink, and Guggenheim Securities are joint book running managers for the offering.

Relmada intends to use the net proceeds to fund research and development for clinical stage programs related to its lead product candidate, REL-1017 (d-methadone), an oral agent for depression which recently produced favorable results in clinical trials.

Sichenzia Ross Ference LLP also represented Relmada in the listing of its Common Stock on the Nasdaq Capital Market, which commenced trading on October 10, 2019. The firm joined Relmada and its executive leadership at its Nasdaq Bell Ringing Ceremony on October 17.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Barrett DiPaolo, Thomas Rose and Associate Grant Levine.

Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article

Press Release – New York, NY – December 6, 2019Sichenzia Ross Ference (SRF) trust and estate attorneys Jodi Zimmerman and Robert Birnbaum were quoted in a LegalZoom article entitled Including Your Stepchildren in Your Estate Plan, written by Sandra Beckwith. Zimmerman and Birnbaum elaborate on tips for preparing wills and trusts to include stepchildren and how to effectively communicate your wishes to loved ones.

You can read the full article here.

Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement

H-Cyte

Press Release – New York, NY – December 2, 2019 –  Sichenzia Ross Ference LLP acted as H-Cyte’s counsel in a $6.0 million private placement with FWHC, LLC at a price in excess of the market price. H-Cyte is the owner and operator of innovative medical technology products and services including LungCYTE and The Lung Health Institute. H-Cyte intends to utilize the funds to advance its development of industry-leading medical treatments for chronic lung diseases such as COPD. The SRF team was led by partner, Arthur Marcus.

Time to Make a Personal Estate Plan for Your (Financial) Exit or IPO

Your years of hard work have finally come to fruition.  Your company is going to go public or your business is going to be sold and what was once a dream is now about to become a reality.  This is the time when many entrepreneurs make million-dollar mistakes and forget about their partner Uncle Sam.  He has been waiting patiently in the wings for you to get rich; the richer you get, the happier he is.

The United States does not have a wealth tax yet, and it may never have one unless Elizabeth Warren is elected President.  However, it does have a death tax and so do a number of states, including New York; the less you plan the higher the death tax will be.  Whether your company will be going public or will be sold privately, you will be in a position to potentially save millions in estate taxes by putting a solid estate plan in place to protect your family.

Here’s the bad news: right now, the federal government has a death tax that will take 40% of everything you own over $11,400,000.  The amount exempt from tax is scheduled to be cut in half in a few years and possibly sooner, depending on the 2020 election.  Many States take a bite as well; for example if you live in New York, the State government has a death tax with rates that could take up to 16% of your assets.

But there’s good news: your company going public or selling your business presents you with an opportunity to potentially save millions in taxes.  It also enables you to structure a plan that will benefit your family and provide for their future well-being for many decades to come.  For more information and guidance on how this can be accomplished, please get in touch with Robert Birnbaum at rbirnbaum@srf.law or Jodi Zimmerman at jzimmerman@srf.law of our Trusts and Estates department. You can also call our office at (212) 930-9700 to speak with our attorneys.

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $3.5 Million Public Offering for Safe-T Group Ltd.

safe-t

Press Release – New York, NY – November 5, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and warrants of Safe-T Group Ltd., a provider of Secure Access solutions for on-premise and hybrid cloud environments (NASDAQ, TASE: SFET).

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in a $1.8 Million Private Placement

document security systems logo

New York, NY – November 5, 2019 – Sichenzia Ross Ference LLP, announced today that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technology, in a private placement of 6,000,000 shares of the company’s common stock at a purchase price of $0.3037 per share. DSS received gross proceeds of $1,822,200 from the offering, which was funded entirely by the company’s Chairman of the Board of Directors, Mr. Heng Fai Ambrose Chan. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

co crystal pharma inc

Press Release – New York, NY – November 4, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q3

srf square banner

Press Release – New York, NY – October 23, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the third quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities. Read PlacementTracker’s full press release here.

Attorneys Selected for Inclusion on 2019 Super Lawyers Lists

Press Release – New York, NY – October 15, 2019 – Sichenzia Ross Ference LLP, a leading corporate and securities law firm, announced today that seven of its attorneys were recognized by Super Lawyers Magazine for 2019. Those Sichenzia Ross members include:

  • Partner A.R. John Hitchings, Partner Jay Yamamoto, Associate Owen A. Kloter, and Associate Gary Varnavides were all named New York Metro Rising Stars for 2019
  • Founding Partner Michael Ference and Partner Sameer Rastogi were recognized for their work in the Securities Litigation category
  • Founding Partner Gregory Sichenzia was recognized for his work in the Securities and Corporate Finance category

Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing

Press Release – New York, NY – October 15, 2019Sichenzia Ross Ference LLP founding partner Gregory Sichenzia will join representatives of client Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical stage, specialty pharmaceutical company, focused on treatment solutions for depression, CNS and ophthalmological disorders, at the Nasdaq MarketSite in Times Square to ring the October 18 opening bell.

Mr. Sichenzia will take the stage along with a group of Relmada Therapeutics leaders, including Chief Executive Officer Sergio Traversa, PharmD, MBA. You can tune in October 18 at 9:30am EST on Facebook Live or via the Nasdaq Webcam. 

Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting

New York, NY – October 10, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by Gregory Sichenzia and partner Barrett DiPaolo. The up-listing is effective for trading on October 10, 2019, and RLMD’s common stock will trade under its existing stock symbol, “RLMD.”

continue reading >>

Founding Partner Marc J. Ross, Esq. Speaks at CBD Mountain Exposition in Denver, CO

Press Release – New York, NY – October 9, 2019 – Sichenzia Ross Ference LLP founding partner Marc. J. Ross Esq., will speak at the CBD Mountain Exposition on October 12, 2019 at the Colorado Convention Center in Denver, Colorado. His presentation, titled “It’s Legal, Or Is It? – A Look At The Legalities Of CBD,” will observe and dissect the law encompassing CBD to clarify and explain legal issues surrounding CBD. The presentation is part of a two day symposium from October 11-12, 2019 that brings the cannabis and CBD industry together for learning, sharing, connecting and business building.

Please visit the website here to purchase tickets or learn more.

Sichenzia Ross Ference Represents Innovative Cosmetic Concepts in Joint Venture

Press Release – New York, NY – October 4, 2019 – Sichenzia Ross Ference LLP acted as counsel for Innovative Cosmetic Concepts LLC (“ICC”) in a joint venture with an entity controlled by Rachel Levin. ICC is a global manufacturer and distributor of high quality cosmetic and personal care products. Rachel Levin is a social influencer with the fastest growing YouTube Channel in the world “RCH Beauty101” with over 14 million subscribers. The SRF team was led by partner, Arthur Marcus.

Sichenzia Ross Ference Represents Pareteum Corporation in $40 Million Offering of Common Stock and Warrants

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – September 27, 2019 – Nationally-recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: “TEUM”), global cloud software communications platform company, in an underwritten public offering of 18,852,273 Common Stock Units, each consisting of one share of TEUM’s common stock, one Series A Purchase Warrant to purchase one share of TEUM’s common stock, and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock, and 3,875,000 Pre-Funded Units, consisting of one pre-funded warrant to purchase one share of TEUM’s common stock together with one Series A Purchase Warrant to purchase one share of TEUM’s common stock and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock.

continue reading >>

Founding Partner Marc J. Ross, Esq. Quoted on New Jersey’s Review of CBD Use in Brownie Ingredients

Press Release — September 30, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. was quoted in an NJ.com story entitled CBD is an ingredient in N.J. brownies, beers and high-end dinners. The FDA says that’s illegal. Marc describes outcomes stemming from FDA review, and is quoted on New Jersey’s ambitions for trying to get ahead of the curve and address what they think is right with its citizens.

Please read the full article here.

Founding Partner Marc J. Ross, Esq. Presents Legal Webinar on The Business and Law of Marijuana

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. presented a webinar course for the Clear Law Institute, titled “The Interplay Between State Laws Legalizing Recreational and/or Medical Marijuana Uses and the Federal Controlled Substance Act,” on Wednesday, September 18, 2019. The presentation, which is Continuing Legal Education (“CLE”) accredited, discussed the interplay between state and federal laws legalizing recreational and/or medical marijuana uses.

To purchase this webinar, please visit the website here and include speaker code MRoss231979 for a 35% discount.

Founding Partner Marc J. Ross, Esq. Speaks About Cannabis at NECANN New Jersey Cannabis Convention

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. spoke  at the New Jersey Cannabis Convention, presented by NECANN on September 15, 2019 at the A.C. Convention Center in Atlantic City. This presentation addressed the “Budding Business Opportunities” and covered a variety of issues ranging from banking, to taxes, to CBD and ethical issues. The two-day symposium will bring the cannabis industry together for learning, sharing, connecting and business building.

Learn more about the event by visiting the website.

Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Bannerman Resources Limited on OTCQB Listing

Press Release – New York, NY – September 18, 2019 – Sichenzia Ross Ference LLP announced today that it sponsored Bannerman Resources Limited (OTCQB: “BNNLF”), an Australian uranium exploration and development company, for the OTCQB. Sichenzia Ross Ference is a qualified firm responsible for providing guidance on OTCQB requirements and recommending membership. The SRF team was led by partner Darrin Ocasio.

Sichenzia Ross Ference Founding Partner Gregory Sichenzia to Moderate Cannabis Panel at the Investor Summit Microcap Conference

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP announced today that founding partner Gregory Sichenzia will moderate the Cannabis panel discussion at the Investor Summit Microcap Conference at 12pmET on September 16th at the Essex House overlooking Central Park in New York City. To register for the event, please click here.

The panel will consist of industry thought leaders including Medicine Man Technologies, Emerald Bioscience, Hillstreet Beverage, Flowr, and Power REIT. The group will discuss the growth of the cannabis industry, recent M&A trends, U.S. regulations, and medical research.

Sichenzia Ross Ference LLP Announces its Gold-Level Sponsorship of the H.C. Wainwright 21st Annual Global Investment Conference

Press Release — September 6, 2019 — New York, NY —Sichenzia Ross Ference LLP is a proud Gold-Level sponsor of the H.C. Wainwright 21st Annual Global Investment Conference. The conference will be held from September 8 through September 10, 2019 at the Lotte New York Palace Hotel.

Many of our partners and clients will be attending the conference, and members of the firm will be available to meet there.

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $2.0 Million Private Placement

Press Release­­ – New York, NY – August 28, 2019 – Sichenzia Ross Ference LLP announced today that it has represented the placement agent in the initial $2.0 million closing of a private placement of common stock of a development stage artificial intelligence software company.  The issuer may raise up to an additional $3.0 million in subsequent closings.  The Sichenzia Ross Ference LLP team was led by partners Michael Ference and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,813,559 shares of Avinger, Inc. (NASDAQ: AVGR) common stock, at a price of $1.18 per share for gross proceeds of approximately $4.5 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $2.3 Million Public Offering of Common Stock of Sigma Labs, Inc.

sigma labs logo

Press Release – New York, NY – August 2, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 2.875 million shares Common Stock of Sigma Labs, Inc. (NASDAQ: SGLB) at a price of $.80 per share for gross proceeds of $2.3 million.  Sigma Labs is a provider of quality assurance software under the PrintRite3D brand.

continue reading >>

SRF Founding Partner Gregory Sichenzia Featured in Authority Magazine Interview Series on Investing in Cannabis

Press Release — August 1, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Gregory Sichenzia was interviewed by Len Giancola, as part of a series on investing in the cannabis industry for Authority Magazine. Authority Magazine frequently profiles thought-leaders and experts spanning multiple industries including business, film, sports and technology.

In his interview, Mr. Sichenzia shared stories and lessons learned from his career as well as tips and insights on what investors need to understand about the growing cannabis industry.

Please read the full Q&A here.

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q2  

Press Release – New York, NY – July 24, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the second quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

immuron logo

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

continue reading >>

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

realwear inc logo

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

continue reading >>

1 2 3 10